Small cell lung cancer: strategies to optimize chemotherapy response.

Cancer journal (Sudbury, Mass.)

Volumn 7 Suppl 1, Issue , 2001, Pages

  Psyrri, A ^a   Murren, J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LUNG TUMOR; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SMALL CELL CARCINOMA; SURVIVAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CYTOKINES; DRUG ADMINISTRATION SCHEDULE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035408531     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)